Significo, a company focused on the fields of health, AI, and digital therapeutics, has raised a Series B funding round. This round was led by JSTAR Capital Investments’ Horizon Fund II, which has significantly contributed to bolstering the company’s financial position. With this latest funding, Significo’s valuation has reached $100 million, paving the way for the company to accelerate its strategic agenda of acquiring and integrating digital health firms that align with its objectives.
The funding will enable Significo to broaden its portfolio of products and services. By doing so, the company intends to enhance its presence in a healthcare industry that is becoming increasingly fragmented due to the rapid growth of digital health solutions. Significo aims to play a key role in consolidating these widely diverse digital health offerings, thus creating a more cohesive ecosystem that benefits both providers and patients.
As part of its expansion strategy, Significo is actively exploring acquisition opportunities that complement its existing product lineup. Key offerings include Balm, an innovative digital therapeutic and condition management platform designed to help patients effectively manage their health conditions, and Recco, a personalized health recommendation engine that provides users with tailored health insights. The integration of these types of acquisitions would strengthen Significo’s overall capabilities and market authority.
The Series B funding follows a notable period of strong commercial traction for Significo. The company has formed partnerships with leading health systems, insurers, and distribution networks, which have strengthened its market position. By consolidating proven digital therapeutics into a unified platform, Significo not only reduces fragmentation but also enhances patient engagement. These efforts demonstrate a viable model for the reimbursement and widespread adoption of digital therapeutics.
How the funding will be used: This new funding will also help to accelerate various growth initiatives across the company. And these initiatives include ongoing product development, plans for global expansion, and the pursuit of strategic acquisitions.
KEY QUOTES:
“Digital health is at an inflection point. Patients, providers, and payors are looking for scalable, clinically validated solutions that deliver real outcomes. With JSTAR Capital Investments’ backing, Significo is not only poised to scale our own platforms but also to bring together best-in-class digital health innovations under one roof. Our goal is to simplify technology adoption for healthcare providers to drive meaningful health outcomes at the population scale.”
Rick McCartney, CEO of Significo
“We are excited to lead this financing round and support Significo in its mission to transform the digital health landscape. The team has a proven track record of execution, and their vision for consolidation and clinical impact is exactly what the industry needs” adds Evan Pritchard, Managing Director of JSTAR Capital Investments.
Jared Leger, Managing Director at JSTAR Capital Investments
